Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 7, 2004

View Archived Issues

Novel anti-H. pylori agents designed by Kotobuki scientists

ARS presents new prostaglandin FP receptor antagonists and their use

New lipid A analogues with immunosuppressant activity discovered at Sankyo

Pirfenidone effective against cirrhosis in vivo

Phase I study for SPRC-AB01

ConjuChem updates progress of DAC:GLP-1 development

OGX-011 reduces expression of a protein that promotes cell survival in prostate cancer

Nippon Shinyaku grants Ivax license to HMN-214

Good safety profile of the Taxus Express2 stent in clinical trials and postmarketing registries

Mallinckrodt claims radiolabeled D-amino acids for cancer diagnosis and therapy

Two novel series of HDAC inhibitors patented by Fujisawa

Enanta scientists present two new series of erythromycin-based antibiotics

Roche scientists describe new selective GlyT-1 inhibitors

FDA extends review period for MS-325

ZymoGenetics licenses rFactor XIII to Novo Nordisk

Squalamine granted fast track status for wet AMD

Phase I study for Hematide

Santarus launches Zegerid

Triton BioSystems licenses ING-1 antibody from Xoma

Stellar Biotechnologies awarded NCI grant for KLH development

OraDisc A approved for aphthous ulcers

Neupro submitted for approval in U.S., Europe for Parkinson's disease

Fast track designation for MDX-010 in metastatic melanoma

Antiinflammatory agent by Uriach promising for the treatment of IBD

The inhibition of ADAM metalloproteases may present a novel approach for treatment of cancer

Targeting skeletal metastases in prostate cancer

Regulation of tumor angiogenesis and cell survival by integrin-linked kinase

Germany marks first European launch of Raptiva

Infliximab reported to reduce pain associated with Crohn's disease

Degarelix reduces testosterone and PSA levels in prostate cancer patients

Sildenafil and antidepressants improve premature ejaculation

Therapeutic effects and quality of life improvements of darifenacin in overactive bladder patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...